General Information of Drug (ID: DMOMVW9)

Drug Name
NPC-15669 Drug Info
Synonyms
Npc-15669; Npc 15669; UNII-K6JBN2T3Z4; K6JBN2T3Z4; N-(9H-(2,7-Dimethylfluoren-9-ylmethoxy)carbonyl)leucine; N-(((2,7-Dimethyl-9H-fluoren-9-yl)methoxy)carbonyl)-L-leucine; L-Leucine, N-(((2,7-dimethyl-9H-fluoren-9-yl)methoxy)carbonyl)-; AC1L3OOH; 132684-62-9; CHEMBL42385; SCHEMBL8066678; LS-187592; LS-186942; (2S)-2-[(2,7-dimethyl-9H-fluoren-9-yl)methoxycarbonylamino]-4-methylpentanoic acid
Indication
Disease Entry ICD 11 Status REF
Inflammation 1A00-CA43.1 Discontinued in Phase 1 [1]
Cross-matching ID
PubChem CID
119365
CAS Number
CAS 132684-62-9
TTD Drug ID
DMOMVW9

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Polymorphonuclear neutrophil adhesion (PMNA) TTJAY96 NOUNIPROTAC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001544)
2 NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-coupled signal transduction. Br J Pharmacol. 1995 Apr;114(8):1694-702.